NEUROLOGIC ASSESSMENT IN NEURO-ONCOLOGY (NANO) SCALE IN A PHASE II STUDY OF PEMBROLIZUMAB OR PEMBROLIZUMAB PLUS BEVACIZUMAB IN PATIENTS WITH RECURRENT GLIOBLASTOMA

被引：0

作者：

Nayak, Lakshmi ^{[1
]}

Molinaro, Annette ^{[2
]}

Peters, Katherine ^{[3
]}

Clarke, Jennifer ^{[2
]}

Jordan, Justin ^{[4
]}

de Groot, John ^{[5
]}

Nghiemphu, Phioanh ^{[6
]}

Kaley, Thomas ^{[7
]}

Colman, Howard ^{[8
]}

McCluskey, Christine ^{[1
]}

Gaffey, Sarah ^{[1
]}

Smith, Timothy ^{[9
]}

Cote, David ^{[10
]}

Severgnini, Mariano ^{[1
]}

Yearley, Jennifer ^{[11
]}

Zhao, Qing ^{[11
]}

Blumenschein, Wendy ^{[11
]}

Duda, Gabriel ^{[4
]}

Muzikansky, Alona ^{[4
]}

Jain, Rakesh ^{[12
]}

Wen, Patrick ^{[1
]}

Reardon, David ^{[13
]}

机构：

[1] Dana Farber Canc Inst, Boston, MA 02115 USA

[2] Univ Calif San Francisco, Dept Neurol Surg, San Francisco, CA USA

[3] Duke Univ, Med Ctr, Durham, NC USA

[4] Massachusetts Gen Hosp, Boston, MA 02114 USA

[5] Univ Texas MD Anderson Canc Ctr, Houston, TX 77030 USA

[6] Univ Calif Los Angeles, Los Angeles, CA USA

[7] Mem Sloan Kettering Canc Ctr, 1275 York Ave, New York, NY 10021 USA

[8] Huntsman Canc Inst, Salt Lake City, UT USA

[9] Brigham & Womens Hosp, Dept Neurosurg, 75 Francis St, Boston, MA 02115 USA

[10] BWH, Boston, MA USA

[11] Merck, Kenilworth, NJ USA

[12] Harvard Med Sch, Massachusetts Gen Hosp, Dept Radiat Oncol, Edwin L Steele Labs, Boston, MA 02115 USA

[13] Dana Farber Canc Inst, Ctr Neurooncol, Boston, MA 02115 USA

来源：

NEURO-ONCOLOGY | 2020年 / 22卷

关键词：

D O I：

暂无

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

NCOG-44

引用

页码：138 / 139

页数：3

共 50 条

[31] PHASE I/II STUDY OF TEMOZOLOMIDE PLUS NIMUSTINE CHEMOTHERAPY FOR RECURRENT MALIGNANT GLIOMAS: KYOTO NEURO-ONCOLOGY GROUP
Aoki, Tomokazu
Arakawa, Yoshiki
Ueba, Tetsuya
Oda, Masashi
Nishida, Namiko
Akiyama, Yukinori
Tsukahara, Tetsuya
Iwasaki, Koichi
Mikuni, Nobuhiro
Miyamoto, Susumu
NEURO-ONCOLOGY, 2016, 18 : 2 - 2
[32] Phase I/II Study of Temozolomide Plus Nimustine Chemotherapy for Recurrent Malignant Gliomas: Kyoto Neuro-oncology Group
Aoki, Tomokazu
Arakawa, Yoshiki
Ueba, Tetsuya
Oda, Masashi
Nishida, Namiko
Akiyama, Yukinori
Tsukahara, Tetsuya
Iwasaki, Koichi
Mikuni, Nobuhiro
Miyamoto, Susumu
NEUROLOGIA MEDICO-CHIRURGICA, 2017, 57 (01) : 17 - 27
[33] Patterns of bevacizumab use in patients with glioblastoma: an online survey among experts in neuro-oncology
Ranjan, Surabhi
Skorupan, Nebojsa
Ye, Xiaobu
Sivakumar, Ananyaa
Yankulina, Olga
Kamson, David Olayinka
Grossman, Stuart A.
Dzaye, Omar
Holdhoff, Matthias
NEURO-ONCOLOGY PRACTICE, 2020, 7 (01) : 52 - 58
[34] PHASE I/II STUDY OF TEMOZOLOMIDE PLUS NIMUSTINE CHEMOTHERAPY FOR RECURRENT MALIGNANT GLIOMAS: KYOTO NEURO-ONCOLOGY GROUP
Aoki, Tomokazu
Arakawa, Yoshiki
Ueba, Tetsuya
Oda, Masashi
Nishida, Namiko
Akiyama, Yukinori
Tsukahara, Tetsuya
Iwasaki, Koichi
Mikuni, Nobuhiro
Miyamoto, Susumu
NEURO-ONCOLOGY, 2019, 21 : 12 - 12
[35] PHASE I/II STUDY OF TEMOZOLOMIDE PLUS NIMUSTINE CHEMOTHERAPY FOR RECURRENT MALIGNANT GLIOMAS: KYOTO NEURO-ONCOLOGY GROUP
Aoki, Tomokazu
Arakawa, Yoshiki
Ueba, Tetsuya
Oda, Masashi
Nishida, Namiko
Akiyama, Yukinori
Aoki, Tomokazu
Iwasaki, Koichi
Mikuni, Nobuhiro
Miyamoto, Susumu
NEURO-ONCOLOGY, 2020, 22 : 49 - 50
[36] A phase II study of lenvatinib plus pembrolizumab in patients with progressive, recurrent/metastatic adenoid cystic carcinoma.
Mohamadpour, Maliheh
Sherman, Eric Jeffrey
Kriplani, Anuja
Fetten, James Vincent
Dunn, Lara
Michel, Loren S.
Hung, Kin Wai
Baxi, Shrujal S.
McDonald, Erin
Conybeare, Rachel
Katabi, Nora
Ostrovnaya, Irina
Pfister, David G.
Ho, Alan Loh
JOURNAL OF CLINICAL ONCOLOGY, 2023, 41 (16)
[37] Pembrolizumab in patients with recurrent thymic carcinoma: Results of a phase II study.
Giaccone, Giuseppe
Thompson, Jillian
McGuire, Colleen
Manning, Maria
Kallakury, Bhaskar
Chahine, Joeffrey J.
Subramaniam, Deepa Suresh
Liu, Stephen V.
Gibney, Geoffrey Thomas
Kim, Chul
McCutcheon, Justine N.
JOURNAL OF CLINICAL ONCOLOGY, 2017, 35
[38] STRATEGY OF THE RECURRENT GLIOBLASTOMA TREATMENT. THREE NEURO-ONCOLOGY CENTERS STUDY
Kalita, O.
Kazda, T.
Reguli, S.
Jancalek, R.
Fadrus, P.
Krska, L.
Slachta, M.
Valosek, J.
Vrbkova, J.
Hrabalek, L.
Smrcka, M.
Lipina, R.
NEURO-ONCOLOGY, 2022, 24
[39] Phase II study of bi-weekly temozolomide plus bevacizumab for adult patients with recurrent glioblastoma
Michael A. Badruddoja
Marjorie Pazzi
Abhay Sanan
Kurt Schroeder
Kevin Kuzma
Thomas Norton
Thomas Scully
Daruka Mahadevan
Michael Malek Ahmadi
Cancer Chemotherapy and Pharmacology, 2017, 80 : 715 - 721
[40] Phase II study of bi-weekly temozolomide plus bevacizumab for adult patients with recurrent glioblastoma
Badruddoja, Michael A.
Pazzi, Marjorie
Sanan, Abhay
Schroeder, Kurt
Kuzma, Kevin
Norton, Thomas
Scully, Thomas
Mahadevan, Daruka
Ahmadi, Michael Malek
CANCER CHEMOTHERAPY AND PHARMACOLOGY, 2017, 80 (04) : 715 - 721

← 1 2 3 4 5 →